Albertsons® Companies, Inc. Appoints Harmit Singh to Board of Directors

BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. Appoints Harmit Singh to Board of Directors.

Business Wire • 4 hours ago

These Analysts Revise Their Forecasts On Albertsons After Q2 Results

Albertsons Companies, Inc. (NYSE:ACI) on Tuesday reported better-than-expected second-quarter fiscal 2026 results.

Benzinga • Oct 14, 2026

Albertsons Is Betting on a Turnaround—But Will It Pay Off?

Albertsons Companies TodayACIAlbertsons Companies$12.75 +0.21 (+1.65%) As of 10/13/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$10.86▼$20.00Dividend Yield5.33%P/E Ratio159.34Price Target$14.62Add to WatchlistAlbertsons Companies NYSE: ACI stock showed signs of bottoming in mid-October, rising by more than 2% following its Q2 fiscal year 2027 (FY2027) earnings report.

MarketBeat • Oct 14, 2026

Albertsons® Announces New Store in Valley Center, Bringing Fresh Food, Pharmacy Services and Jobs to Growing Community

FULLERTON, Calif.--(BUSINESS WIRE)--Albertsons announced plans to build a new Albertsons grocery store in Valley Center, scheduled to open in spring 2028.

Business Wire • Oct 14, 2026

Meg Whitman Takes Charge at Albertsons

“Today's call is going to be a little different,” Susan Morris, CEO of Albertsons, said yesterday, kicking off the grocery and pharmacy company's latest earnings call.

WSJ • Oct 14, 2026

Longleaf Partners Fund Q3 2026 Portfolio Review

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

Seeking Alpha • Oct 14, 2026

Longleaf Partners Global Fund Q3 2026 Portfolio Review

Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.

Seeking Alpha • Oct 14, 2026

Albertsons Pulls FY Guidance, Plans Business Review

The grocery store chain's second-quarter profit came in at $51.5 million, or 11 cents a share, compared with $168.5 million, or 30 cents a share, a year earlier.

WSJ • Oct 13, 2026

US grocer Albertsons suspends full-year forecasts amid business review

Albertsons withdrew its fiscal 2026 forecasts on Tuesday as the grocer reviews its strategy, ​cost structure and portfolio of businesses as part of ‌a turnaround effort.

Reuters • Oct 13, 2026

Albertsons Companies Q2 Earnings Call Highlights

Albertsons Companies NYSE: ACI reported a 0.8% decline in second-quarter identical sales and outlined a broader turnaround effort centered on cost reductions, targeted price investments, operational simplification and a review of its portfolio of businesses and assets.

MarketBeat • Oct 13, 2026